[Treatment of two cases of extramedullary infiltration multiple myeloma with BCMA CAR-T cells]

Zhonghua Xue Ye Xue Za Zhi. 2021 Mar 14;42(3):253-255. doi: 10.3760/cma.j.issn.0253-2727.2021.03.013.

[Article in Chinese]

Authors

Y J Sun¹, X C Liu¹, L Han¹, S S Wu¹, Y Y Liu¹, Q L Gao¹, Y P Song¹, K S Zhou¹

Affiliation

¹ Department of Hematopathy, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.

PMID: 33910313
PMCID: PMC8081939
DOI: 10.3760/cma.j.issn.0253-2727.2021.03.013

No abstract available

MeSH terms

B-Cell Maturation Antigen
Humans
Immunotherapy, Adoptive
Multiple Myeloma* / therapy
Receptors, Chimeric Antigen*
T-Lymphocytes

Substances

B-Cell Maturation Antigen
Receptors, Chimeric Antigen

Grants and funding

基金项目：河南省重大科技专项（182300410347）